FAM45A Activators
FAM45A activators belong to a category of chemical agents that modulate the activity of the protein encoded by the FAM45A gene, whose full name is Family With Sequence Similarity 45 Member A. This protein is a part of a larger group of proteins that are characterized by their sequence similarity and are believed to play a role in various cellular processes. The activators themselves are specialized molecules that interact with FAM45A, leading to an increase in its activity within the cell. The precise mechanism through which these activators exert their effect can vary; it may involve direct interaction with the protein's active site, altering its conformation to an active state, or it could involve the modulation of the protein's expression levels or its stabilization within the cellular environment. The interaction is often highly specific, with activators displaying selectivity towards FAM45A, thereby minimizing unintended interactions with other proteins.
The molecular design of FAM45A activators typically requires an intricate understanding of the protein's structure and the molecular pathways it influences. Research into the structure-function relationship of FAM45A has provided insights into how these activators can be fashioned to fit into particular regions of the protein, often referred to as binding pockets, to exert their activating influence. These compounds can be small molecules, peptides, or other forms of biochemical agents that have been tailored to engage with FAM45A in a manner that promotes its functional activity. The development of such activators often involves iterative cycles of synthesis and testing, with structural modifications made based on the outcomes of binding assays and activity measurements. Through such processes, a series of potential activators can be generated, each with varying degrees of efficacy and specificity in modulating the FAM45A protein's function within cells.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which phosphorylates a wide range of cellular substrates. PKC activation can lead to the signaling cascades that may underlie the activation of FAM45A by modulating its interaction with other proteins or its involvement in cellular processes such as cytoskeletal organization. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that acts as an antioxidant and kinase inhibitor. By inhibiting certain kinases, EGCG could shift the balance of cellular signaling towards pathways that activate FAM45A, such as by affecting cytoskeletal dynamics or cell adhesion processes. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent signaling pathways. These pathways may then enhance the functional activity of FAM45A, especially if FAM45A activity is modulated by calcium-dependent processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of phosphoinositide 3-kinases (PI3K), which can modulate the PI3K/Akt signaling pathway. By inhibiting PI3K, LY294002 could potentiate signaling cascades that lead to FAM45A activation, if FAM45A is involved in processes downstream or affected by PI3K/Akt signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which are kinases in the MAPK/ERK pathway. Inhibition of this pathway can result in the activation of alternative signaling pathways that may involve FAM45A, thereby potentially enhancing its functional activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. Inhibition of p38 can alter signaling dynamics and may activate pathways in which FAM45A is involved, thus enhancing its activity if FAM45A operates in p38 MAPK-regulated processes. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that facilitates the influx of calcium ions, leading to the activation of calcium-dependent signaling pathways. These pathways could indirectly enhance the functional activity of FAM45A by modulating cellular processes that are regulated by calcium signaling, in which FAM45A might play a role. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors, triggering signaling cascades that regulate a variety of cellular events including cytoskeletal changes. Activation of these pathways could lead to the functional enhancement of FAM45A if it is involved in related cellular processes. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that disrupts calcium homeostasis, leading to increased intracellular calcium levels. This can activate calcium-dependent signaling mechanisms, which may enhance the activity of FAM45A by affecting cellular processes such as vesicular trafficking or muscle contraction, where FAM45A could potentially be involved. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor. While it inhibits many kinases, it could selectively activate specific pathways by relieving kinases' inhibitory effects on processes where FAM45A is active, thereby enhancing FAM45A's function if it is involved in such processes. | ||||||